Effects of travoprost on actin cytoskeleton and β-catenin in the human trabecular meshwork cells treated with Dexamethasone

Chinese Journal of Ophthalmology

Volumn 47, Issue 4, 2011, Pages 336-341

  Peng, Jie ^a   Lei, Chun Tao ^a   Hu, Jian Bin ^a   Fan, Ying Chuan ^a  

^a SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Beta catenin; Cloprostenol; Cytoskeleton; Dexamethasone; Trabecular meshwork

Indexed keywords

BETA CATENIN; CLOPROSTENOL; CTNNB1 PROTEIN, HUMAN; DEXAMETHASONE; DRUG DERIVATIVE; TRAVOPROST;

ARTICLE; CYTOLOGY; CYTOSKELETON; DRUG EFFECT; HUMAN; METABOLISM; TRABECULAR MESHWORK;

BETA CATENIN; CLOPROSTENOL; CYTOSKELETON; DEXAMETHASONE; HUMANS; TRABECULAR MESHWORK;

EID: 84860818887     PISSN: 04124081     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0412-4081.2011.04.011     Document Type: Article

References (15)

1. Sanka K, Maddala R, Epstein DL, et al. Influence of actin cytoskeletal integrity on matrix metalloproteinase-2 activation in cultured human trabecular meshwork cells. Invest Ophthalmol Vis Sci, 2007, 48: 2105-2114.
2. Zhang M, Maddala R, Rao PV. Novel molecular insights into RhoA GTPase-induced resistance to aqueous humor outflow through the trabecular meshwork. Am J Physiol Cell Physiol, 2008, 295: C1057-1070.
3. Yu M, Chen X, Wang N, et al. H-1152 effects on intraocular pressure and trabecular meshwork morphology of rat eyes. J Ocul Pharmacol Ther, 2008, 24: 373-379.
4. Liu X, Hu Y, Filla MS, et al. The effect of C3 transgene expression on actin and cellular adhesions in cultured human trabecular meshwork cells and on outflow facility in organ cultured monkey eyes. Mol Vis, 2005, 11: 1112-1121.
5. Sharif NA, Kelly CR, Crider JY. et al. Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells. J Ocul Pharmacol Ther, 2003, 19: 501-515.
6. Bean GW, Camras CB. Commercially available prostaglandin analogs for the reduction of intraocular pressure: similarities and differences. Surv Ophthalmol, 2008, 53 Suppl1: S69-84.
7. Toris CB, Gabelt BT, Kaufman PL. Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction. Surv Ophthalmol, 2008, 53 Suppl1: S107-120.
8. 2006, 42: 341-343.
9. Wade NC, Grierson I, O'Reilly S, et al. Cross-linked actin networks (CLANs) in bovine trabecular meshwork cells. Exp Eye Res, 2009, 89: 648-659.
10. Clark AF, Brotchie D, Read AT, et al. Dexamethasone alters F-actin architecture and promotes cross-linked actin network formation in human trabecular meshwork tissue. Cell Motil Cytoskeleton, 2005, 60: 83-95.
11. Zhuo YH, He Y, Leung KW, et al. Dexamethasone disrupts intercellular junction formation and cytoskeleton organization in human trabecular meshwork cells. Mol Vis, 2010, 16: 61-71.
12. Hoare MJ, Grierson I, Brotchie D, et al. Cross-linked actin networks (CLANs) in the trabecular meshwork of the normal and glaucomatous human eye in situ. Invest Ophthalmol Vis Sci, 2009, 50: 1255-1263.
13. Birchmeier W, Weidner KM, Behrens J. Molecular mechanisms leading to loss of differentiation and gain of invasiveness in epithelial cells. J Cell Sci Suppl, 1993, 17: 159-164.
14. Wang WH, McNatt LG, Pang IH, et al. Increased expression of the WNT antagonist sFRP-1 in glaucoma elevates intraocular pressure. J Clin Invest, 2008, 118: 1056-1064.
15. 2008, 46: 286-290.